98-7551. National Heart, Lung, and Blood Institute; Closed Meetings  

  • [Federal Register Volume 63, Number 56 (Tuesday, March 24, 1998)]
    [Notices]
    [Pages 14127-14128]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-7551]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    
    
    National Heart, Lung, and Blood Institute; Closed Meetings
    
        Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
    amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
    National Heart, Lung, and Blood Institute Special Emphasis Panel (SEP) 
    meetings:
    
        Name of SEP: Prevention of Weight Gain and ``Premier'' Lifestyle 
    Interventions for Blood Pressure Control--Clinical Trial.
        Date: April 3, 1998.
        Time: 8:00 a.m.
        Place: Holiday Inn Silver Spring, 8777 Georgia Avenue, Silver 
    Spring, MD 20910.
        Contact Person: Valerie L. Prenger, Ph.D., Two Rockledge Center, 
    Room 7198, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
    0297.
        Purpose/Agenda: To review and evaluate grant applications.
        This notice is being published less than fifteen days prior to 
    this meeting due to the urgent need to meet timing limitations 
    imposed by the review and funding cycle.
    
        Name of SEP: Retrovirus Epidemiology, Donor Study (REDS) 
    (Telephone Conference Call).
        Date: April 8, 1998.
        Time: 1:00 p.m.
        Place: Rockledge Building, Room 7204, 6701 Rockledge Drive, 
    Bethesda, MD 20892-7924.
        Contract Person: Eric H. Brown, Ph.D., Two Rockledge Center, 
    Room 7204, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
    0299.
        Purpose/Agenda: To review and evaluate contract proposals.
        These meetings will be closed in accordance with the provisions 
    set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
    Applications and/or proposals and the discussions could reveal 
    confidential trade
    
    [[Page 14128]]
    
    secrets or commercial property such as patentable material and 
    personal information concerning individuals associated with the 
    applications and/or proposals, the disclosure of which would 
    constitute a clearly unwarranted invasion of personal privacy.
    
    (Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
    and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
    93-839, Blood Diseases and Resources Research, National Institutes 
    of Health)
    
        Dated: March 17, 1998.
    LaVerne Y. Springfield,
    Committee Management Officer, NIH.
    [FR Doc. 98-7551 Filed 3-23-98; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Effective Date:
4/3/1998
Published:
03/24/1998
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
98-7551
Dates:
April 3, 1998.
Pages:
14127-14128 (2 pages)
PDF File:
98-7551.pdf